Notice of Q1 2020 Trading Update

16 January 2020

UDG Healthcare plc

Notice of Q1 2020 Trading Update

UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the first quarter to 31 December 2019 at 7.00 a.m. (GMT) on Tuesday, 28 January 2020.

The Company will also host a conference call for investors and analysts at 9.00am (GMT) on Tuesday, 28 January 2020 to discuss the statement. The dial-in details are as follows:

Please dial-in to the call 10 minutes before, and quote "UDG Trading Update" when prompted.

A playback facility will be available for seven days on +44 (0)1212604862. The access code for the replay will be 00089765.

For further information, please contact:

Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000

Lisa Kavanagh / Jack Hickey / Ella Morris

Powerscourt

Tel: +44-207-250-1446

Email: [email protected]

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to: www.udghealthcare.com